Linden Thomas Advisory Services’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-17,900
| Closed | -$1.56M | – | 453 |
|
|
2024
Q1 | $1.56M | Buy |
17,900
+17
| +0.1% | +$1.49K | 0.25% | 151 |
|
|
2023
Q4 | $1.72M | Sell |
17,883
-166
| -0.9% | -$16K | 0.32% | 105 |
|
|
2023
Q3 | $1.6M | Sell |
18,049
-542
| -3% | -$48K | 0.36% | 84 |
|
|
2023
Q2 | $1.61M | Buy |
18,591
+80
| +0.4% | +$6.93K | 0.36% | 87 |
|
|
2023
Q1 | $1.8M | Buy |
18,511
+459
| +3% | +$44.6K | 0.45% | 58 |
|
|
2022
Q4 | $1.87M | Buy |
+18,052
| New | +$1.87M | 0.53% | 40 |
|